{
  "resourceType" : "ValueSet",
  "id" : "hiv-c-de72",
  "text" : {
    "status" : "extensions",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><ul><li>Include these codes as defined in <a href=\"CodeSystem-concept-codes.html\"><code>http://fhir.org/guides/itech-uw/who-smart-hiv-dak/CodeSystem/concept-codes</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href=\"CodeSystem-concept-codes.html#concept-codes-HIV.46C.46DE72\">HIV.C.DE72</a></td><td>Dolutegravir (DTG)</td><td>Third-drug for PEP in adults and adolescents - Dolutegravir (DTG)</td></tr><tr><td><a href=\"CodeSystem-concept-codes.html#concept-codes-HIV.46C.46DE73\">HIV.C.DE73</a></td><td>Raltegravir (RAL)</td><td>Third-drug for PEP in adults and adolescents - Raltegravir (RAL)</td></tr><tr><td><a href=\"CodeSystem-concept-codes.html#concept-codes-HIV.46C.46DE74\">HIV.C.DE74</a></td><td>Darunavir/ritonavir (DRV/r)</td><td>Third-drug for PEP in adults and adolescents - Darunavir/ritonavir (DRV/r)</td></tr><tr><td><a href=\"CodeSystem-concept-codes.html#concept-codes-HIV.46C.46DE75\">HIV.C.DE75</a></td><td>Atazanavir/ritonavir (ATV/r)</td><td>Third-drug for PEP in adults and adolescents - Atazanavir/ritonavir (ATV/r)</td></tr><tr><td><a href=\"CodeSystem-concept-codes.html#concept-codes-HIV.46C.46DE76\">HIV.C.DE76</a></td><td>Lopinavir/ritonavir (LPV/r)</td><td>Third-drug for PEP in adults and adolescents - Lopinavir/ritonavir (LPV/r)</td></tr></table></li></ul></div>"
  },
  "url" : "http://fhir.org/guides/itech-uw/ValueSet/hiv-c-de72",
  "version" : "0.3.0",
  "name" : "ThirddrugforPEPinadultsandadolescentsCodes",
  "title" : "Third-drug for PEP in adults and adolescents Codes",
  "status" : "draft",
  "experimental" : false,
  "date" : "2024-03-05T18:24:53+00:00",
  "publisher" : "World Health Organization (WHO) ",
  "contact" : [{
    "telecom" : [{
      "system" : "url",
      "value" : "https://www.who.int"
    }]
  }],
  "description" : "Codes representing possible values for the Third-drug for PEP in adults and adolescents element",
  "jurisdiction" : [{
    "coding" : [{
      "system" : "http://unstats.un.org/unsd/methods/m49/m49.htm",
      "code" : "001"
    }]
  }],
  "immutable" : true,
  "compose" : {
    "include" : [{
      "system" : "http://fhir.org/guides/itech-uw/who-smart-hiv-dak/CodeSystem/concept-codes",
      "concept" : [{
        "code" : "HIV.C.DE72",
        "display" : "Dolutegravir (DTG)"
      },
      {
        "code" : "HIV.C.DE73",
        "display" : "Raltegravir (RAL)"
      },
      {
        "code" : "HIV.C.DE74",
        "display" : "Darunavir/ritonavir (DRV/r)"
      },
      {
        "code" : "HIV.C.DE75",
        "display" : "Atazanavir/ritonavir (ATV/r)"
      },
      {
        "code" : "HIV.C.DE76",
        "display" : "Lopinavir/ritonavir (LPV/r)"
      }]
    }]
  }
}